Detalhe da pesquisa
1.
Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease.
Am J Gastroenterol
; 119(2): 306-312, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737675
2.
Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's disease.
Gastrointest Endosc
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38462057
3.
High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease.
Eur J Clin Pharmacol
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553558
4.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594435
5.
High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.
Clin Gastroenterol Hepatol
; 19(8): 1573-1582.e5, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461138
6.
Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease.
Scand J Gastroenterol
; 56(2): 155-161, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300822
7.
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system.
Pharmacoepidemiol Drug Saf
; 30(4): 520-524, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219593
8.
No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis.
Clin Gastroenterol Hepatol
; 18(8): 1777-1784.e2, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610337
9.
Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study.
Inflamm Bowel Dis
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666643
10.
Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study.
Eur J Gastroenterol Hepatol
; 35(3): 261-269, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708296
11.
Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry.
Aliment Pharmacol Ther
; 57(1): 117-126, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282200
12.
Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk Stratification.
J Crohns Colitis
; 17(2): 221-230, 2023 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094558
13.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(4): 343-355, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736339
14.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
J Crohns Colitis
; 17(11): 1771-1780, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310877
15.
Detection of anal sphincter defects in female patients with fecal incontinence: a comparison of 3-dimensional transperineal ultrasound and 2-dimensional endoanal ultrasound.
Dis Colon Rectum
; 55(6): 646-52, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22595843
16.
De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation.
Eur J Gastroenterol Hepatol
; 34(5): 488-495, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34974465
17.
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.
Inflamm Bowel Dis
; 28(12): 1813-1820, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134917
18.
Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed.
J Clin Med
; 11(22)2022 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36431320
19.
Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn's disease.
Eur J Gastroenterol Hepatol
; 34(10): 983-992, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062493
20.
Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.
J Crohns Colitis
; 15(1): 162-164, 2021 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588044